Recently, germline variants in SAMD9 and SAMD9L have been reported in clinical syndromes affecting multiple organ systems that are also associated with MDS and monosomy 719-22, as well as isolated familial MDS23. This evidence concerns the gene SAMD9 and myelodysplastic syndrome.